XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2024
Revenue  
Summary of revenue disaggregated by product

Three Months Ended

Nine Months Ended

September 30,

September 30,

(In thousands)

    

2024

2023

2024

2023

Revenue

Lymphedema products

$

65,282

$

62,506

$

182,278

$

172,257

Airway clearance products

7,811

7,080

25,121

24,514

Total

$

73,093

$

69,586

$

207,399

$

196,771

Percentage of total revenue

Lymphedema products

 

89%

 

90%

 

88%

 

88%

Airway clearance products

11%

10%

12%

12%

Total

 

100%

 

100%

 

100%

 

100%

Summary of revenue by channel

Three Months Ended

Nine Months Ended

September 30,

September 30,

(In thousands)

    

2024

2023

2024

2023

Private insurers and other payers

$

47,564

$

39,376

$

122,907

$

101,300

Veterans Administration

8,442

7,259

23,339

20,203

Medicare

9,276

15,871

36,032

50,754

Durable medical equipment distributors

7,811

7,080

25,121

24,514

Total

$

73,093

$

69,586

$

207,399

$

196,771

Sales-type lease revenue and the associated cost of goods sold

Three Months Ended September 30,

Nine Months Ended September 30,

(In thousands)

2024

2023

2024

2023

Sales-type lease revenue

$

9,925

$

10,720

$

26,657

$

25,312

Cost of sales-type lease revenue

 

2,703

 

3,211

 

8,270

 

9,122

Gross profit

$

7,222

$

7,509

$

18,387

$

16,190